This paper reviews the relative strengths and weaknesses of outcome and process measures as performance indicators in health care. Differences in outcome may be due to case mix, how the data were collected, chance, or quality of care. Health care is only one determinant of health and other factors have important effects on health outcomes, such as nutrition, environment, lifestyle and poverty. The advantages of process measures are that they are more sensitive to differences in the quality of care and they are direct measures of quality. However, outcome measures are of greater intrinsic interest and can reflect all aspects of care, including those that are otherwise difficult to measure such as technical expertise and operator skill. Outcome indicators can be improved if efforts are made to standardize data collection and case mix adjustment systems are developed and validated. It is argued that this is worth doing only where it is likely that variations in health care might lead to significant variations in health outcome and where the occurrence of the outcome is sufficiently common that the outcome indicator will have the power to detect real differences in quality. If these conditions are not met, then alternative strategies such as process measurement and risk management techniques may be more effective at protecting the public from poor quality care.
to consider in which circumstances it might be appropriate High-profile failures of health care in the UK have kept the to use outcome measures to monitor health care. In order spotlight on methods to monitor the quality of health services.
to do this, it is important to consider the different contexts Hot on the heels of the 'Bristol case', a 'once in a lifetime in which this debate is taking place. drama' [1] in which three doctors were found guilty by the General Medical Council of 'serious professional misconduct'
A question of perspective in relation to the deaths of 29 babies and young children undergoing paediatric cardiac surgery, came the 'Shipman An important contextual issue is the purpose for which the case' [2] . Shipman was a British General Practitioner who performance indicator is to be used and by whom. The aim was convicted of murdering 15 of his patients, although he of using performance indicators may be to: is suspected of murdering many more. A recent analysis suggests that monitoring outcome could have identified siginform policy making or strategy at a regional or national nificant deviations from expected mortality rates in both level, these examples [3] . Others have argued that taking such an improve the quality of care of a health care facility, approach might distract from more mundane methods that monitor performance of health care funders such as HMOs, nevertheless may be more effective at protecting patients identify poor performers to protect public safety against poor care [4] . The debate over what are the most provide consumer information to facilitate choice of health useful types of performance indicator to monitor the quality care provider of health care is of international concern [5]. It is simplistic to view process and outcome measures as being in comAt the national level, performance indicators can be used in two ways; to compare performance between countries and petition with each other, but there are circumstances where one type of measure is likely to be more useful than the to inform policy within a country. The summary measure of population health developed by the World Health Orother. The aim of this paper is to review the relative strengths and weaknesses of outcome measures compared with process ganization, disability-adjusted life expectancy (DALE), allows direct comparison of the health of countries, which can raise measures as performance indicators for health care and so important health policy questions, though methodological the type of patient that are cared for by the different providers. concerns currently limit the usability of the data [6, 7] . Within Factors such as age, gender, co-morbidity, severity of disease a country, use of population outcome data can help formulate and socio-economic status would come under consideration and monitor health policy. Health care is only one determinant here. The importance of this cause of variation is illustrated of health. Historically, other factors, such as nutrition, en-by studies where differences in crude outcome rates disappear vironment, lifestyle, poverty and social structure of society when the rates are adjusted to take account of these conhave been demonstrated to have powerful effects on health founding factors. For example, the introduction of a stroke as measured by mortality rates [8, 9] . Contemporary data unit in Edinburgh, Scotland, was associated with a 40% suggest that these factors continue to play an important role. reduction in mortality of stroke patients admitted to hospital. For example, changes in lifestyle, in particular diet and However, this difference disappeared once the results were smoking, appear to account for two-thirds of the 31% decline adjusted for case mix [16] . in coronary heart disease that occurred between 1980 and A second cause of variation in outcome is differences in 1992 in US women [10] . Similarly, changes in the prevalence the way data are collected. An outcome indicator used as a of risk factors appear to have accounted for half of the performance indicator has different component parts. For reduction in coronary heart disease mortality that has been example, if the outcome measure is a dichotomous variable observed in recent years in countries such as Scotland and such as death, these comprise a numerator, a denominator New Zealand [11, 12] . Setting mortality targets can encourage and case-mix data used to adjust for potential confounding. policy makers and government to consider policies and Differences in the measurement of any of these will lead to actions outside the direct confines of the health care system apparent differences in outcome. For example, an important that might have an impact on health. For example, the factor in explaining an observed decline in case-mix adjusted mortality targets set by the UK government for diseases such mortality from cardiac surgery in New York State is an as heart disease, stroke and cancer were accompanied by an apparent increase in the prevalence of risk factors in the explicit inter-sectoral strategy for health. This emphasized patients upon whom surgery was performed [17] . Between the importance of non-health care factors as diverse as the 1989 and 1991, there was an increase in the reported prerestriction of sale of cigarettes to underage smokers, the cost valence of renal failure, congestive heart failure, chronic of fruit and vegetables and unemployment [13] .
obstructive pulmonary disease and unstable angina in patients A narrower perspective is obtained if one takes as one's undergoing cardiac surgery. These increases are likely to have population of interest those who are admitted to hospital. reflected changes in how these risk factors were ascertained, For example, 70% of deaths from acute myocardial infarction rather than genuine changes in case mix. If this is the case, occur in people who never reach hospital [14] . This moves then this would account for 40% of the observed reduction the agenda from disease prevention (whether by agencies in case-mix adjusted mortality. within or outside the health service) to disease treatment.
Thirdly, observed differences may be due to chance. For This is relevant to bodies such as Health Maintenance Or-example, in the European Carotid Surgery Trial, the risk of ganizations (HMOs) in the US or primary care groups and major stroke or death within 30 days of carotid entrusts in the UK who, as part of their remit, need to monitor darterectomy was 7% (95% confidence interval, 5.8-8. 3 ). the quality of the hospital services that they procure. This is One hundred and forty-seven surgeons took part in this trial also an appropriate breadth of perspective for health care and surgeon-specific mortality was in the range of 0-50%. providers seeking to improve the quality of their own care However, because of the small number of patients included through such mechanisms as clinical audit. This perspective in the trial by each surgeon, one cannot conclude either that is also of relevance to the public, whether to promote market the surgeons with no operative strokes or deaths were better competition in privately funded health services or public than the rest, or that the surgeon with a 50% complication accountability of state-financed health care [15] . rate was worse, as these differences might have arisen by In general, the broader the perspective required, the greater chance [18] . Random variation is influenced both by number the relevance of outcome measures, since they reflect the of cases included and the frequency with which the outcome inter-play of a wide variety of factors, some directly related occurs. For example, to detect a 30% difference in outcome to health care, others not. As the perspective narrows, to between two units performing carotid endarterectomy with hospitals, or to departments, or indeed to individual doctors, 80% power at a significance level of 5%, with one unit outcome measures become relatively less and process measachieving a 7% death and complication rate and another ures relatively more useful. In order to consider why this is unit a 10% rate, would require the audit of 1422 carotid the case, it is necessary to explore the possible causes of endarterectomies in each unit. Given that hospitals in New variation in outcome between health care providers.
York State each performed on average 50 carotid endarterectomies a year in 1995 [19] , such a difference is unlikely What causes variation in outcome between to be detected. Conversely, to detect a 30% difference in health care providers?
outcome between units treating patients with myocardial infarction, with one unit experiencing a 30% mortality and There are four major categories of explanation that need to the other unit a 21% mortality, would only require the audit be considered, as shown in Table 1 . The first of these is whether observed differences might be due to differences in of 389 patients in each unit [20] . Because this number of Finally, differences in outcome may reflect genuine dif-Similarly, one cannot conclude that the lack of difference in mortality of patients admitted to hospital with stroke in ferences in quality of care. This may be due to variations in the use of interventions, such as use of aspirin and beta-Edinburgh after the introduction of a stroke unit reflects a failure of the stroke unit [16] . To be confident that the stroke blockers in acute myocardial infarction [21], or less measurable aspects such as the skill of a surgeon or of a cardiac arrest unit had failed in bringing about a reduction in mortality that would be consistent with the trial evidence would have team. It is these possible causes of variation that are of relevance if an outcome measure is to be used as a per-required a 10 year study [22] .
A second advantage of process measures is that they are formance indicator. In this circumstance, the conclusion that a variation in outcome is due to a difference in quality of easy to interpret. A process measure such as use of aspirin in acute myocardial infarction is a direct measure of quality, care is essentially a diagnosis of exclusion. If one cannot explain the variation in terms of differences in the type of whereas hospital-specific mortality from myocardial infarction is only an indirect measure. As discussed above, if differences patient, in how the data were collected, or in terms of chance, then quality of care becomes a possible explanation. However, in outcome are observed, then alternative explanations need to be considered before one can conclude that the difference the conclusion that differences in outcome are due to differences in quality of care will always be tentative and open reflects true variations in the quality of care. Conversely, a process measure is straightforward to interpret: the more to the possibility that the apparent association between a given unit and poor outcome is due to confounding by some people without contra-indications who receive a proven therapy, the better. A consequence of this is that the necessary other factor that was not measured, or measured inadequately. These alternative explanations of variation limit the value remedial action is clearer (use the therapy more often). However, if one does conclude that a higher mortality rate of outcome measures as performance indicators of health care. Process measures have two important advantages over is due to poor quality of care, it is not immediately obvious what action needs to be taken, unless perhaps audits of outcome measures, as discussed below.
the process of care have also been undertaken in parallel. Depending upon perspective (see above), this may not be a Advantages of process measures problem. If the information is to be used by purchasers or An important consideration is the extent to which an indicator consumers of health care to influence choice of provider will detect a genuine difference in quality. An intrinsic ad-(and so improve market efficiency), then the underlying cause vantage of process measures is that they are more sensitive of the differences in quality of care is arguably of less than outcome measures to differences in the quality of care. importance. For example, if real differences in the quality of care arising Outcome measures do, however, have a role in the monifrom differential use of proven interventions between two toring of the quality of health care, in that they do have hospitals treating patients with myocardial infarction resulted some intrinsic advantages. in a 10% relative difference in hospital-specific mortality rates (30% versus 27%), it would require following up 3619 patients Advantages of outcome measures in each hospital to detect such a mortality difference and be confident that it was not due to chance (with 80% power at One attraction of outcome measurement is that it is a measure of something that is important in its own right. It is interesting a significance level of 5%) [20] . In a typical UK hospital, this would need 8 years of data collection. However, if one to know that the death rate from myocardial infarction varies from hospital to hospital, even if the reasons for the measured the uptake of the proven interventions that would lead to such a mortality difference, it would only be necessary differences have nothing to do with the quality of care. A process measure is only of value if it is assumed to have a case mix data to allow risk-adjusted rates to be derived?
(Given that process measures offer an easier to interpret and link to outcome. By itself, the process measure is of little less costly alternative). intrinsic interest.
The first issue to consider is the extent to which Secondly, outcome measurement will reflect all aspects of variations in quality of care might lead to significant the processes of care and not simply those that are measurable variations in outcome. Taking stroke care as an example, or measured. Attributes such as technical expertise and opa reasonable estimate of the impact that good quality care erator skill, while likely to be important determinants of might have on outcome is provided by the overview of outcome in some situations, cannot easily be captured as trials looking at the effect of organized inpatient care for performance indicators. Where how you do something is as stroke [26] . This concluded that stroke unit care was important as what you do, process measures will be unable associated with a 17% reduction in the odds of death to capture the distinction [23] . Thus, where technical skill is after 1 year. Observed variations in outcome following relatively unimportant (e.g. giving an aspirin tablet), then the hospital admission with stroke are much greater than this process measure is satisfactory. Where the technical skill is [27] . This suggests that the bulk of the observed variation important (e.g. performing coronary angioplasty or carotid in mortality is likely to be due to differences in case mix endarterectomy), it not only matters that the procedure is than to differences in quality of care. If large differences performed on the correct patients (a process measure), but in mortality persist after case mix adjustment, then the also how well the procedure was carried out.
likeliest explanation is that the case mix adjustment was Another possible reason why outcome indicators are often inadequate. In such circumstances, it is probably not worth used in some countries is that the data, at least to construct spending resource on developing case mix adjustment simple rates, are available from routine information systems.
systems (and standardising the collection of all the additional Hospitals will routinely record the admission diagnosis and data that this would entail) to refine the outcome indicator, other data that can be used for simple case mix adjustment, since it is unlikely to be able to detect real differences in such as age, gender and place of residence. In the UK, quality. However, in circumstances where one might anprocess data has been less readily available in the past and ticipate that quality of care was a substantial determinant has required retrospective case note reviews. This is not an of outcome, then outcome measures are likely to be of issue in countries such as the US where process data are more value as an indicator of quality. For example, mortality required to support the construction of charges for health care.
following surgery is likely to depend to a significant extent As the importance of process indicators becomes recognized, upon the skill and technique of the surgeon. Indeed, for prospective process data are more likely to be recorded in some operative procedures, the benefits of the surgery are other countries. For example, in the UK, the government's outweighed by the potential harms if the complication rate National Service Framework for Coronary Heart Disease, is high: a review of the evidence on carotid endarterectomy specifies process measures that health care providers need concluded that it is effective only if performed by surgeons to record and on which their performance will be who have complication rates of less than 6% [28] . In such monitored [24] .
instances, it is likely to be of value to use case mix adjustment systems [29] , since residual variation is more When to use outcome indicators?
likely to reflect quality of care. The major problem with outcome measures as performance
The second issue to take into account is whether the indicators are that they are not a direct measure of quality outcome indicator is likely to have the statistical power to of health care in the same way that process measures are. A detect differences in quality. Statistical power depends upon patient admitted to hospital with a heart attack may receive how common is the occurrence of the outcome. Since the atrocious care, yet despite this, is likely to survive [25] . target complication rate in carotid endarterectomy is low However, steps can be taken to minimize the possibility of (6%), monitoring outcome will only have limited ability to a false conclusion being drawn about the quality of care based detect whether an individual surgeon's true complication on outcome measurement. Including sufficient numbers of rate is greater than 6%. For example, if a surgeon's 'true' patients will reduce the possibility of random variation mask-complication rate was 8%, one would need to monitor the ing real differences or making spurious differences appear. outcome of 1200 operations to detect that this surgeon's rate Statistical significance testing can also minimize the possibility was greater than 6% with 80% power at a significance level of the latter type of error. Standardising how data are collected of 5%. Thus, in circumstances where the expected outcome can reduce the extent to which differences in measurement is relatively rare, outcome indicators will only have limited can be the cause of observed variation. Development of power to detect real differences in quality. sophisticated case mix adjustment systems can reduce the Finally, one needs to consider whether there are any possibility that observed differences are due to differences practical alternatives to using outcome indicators in a given in the types of patient that are treated. The question is in area. If there is no evidence that a measure of process is what circumstances is it worth going to the effort and linked to outcome, then there is little justification for using expense of setting up an outcome monitoring system covering such a measure, unless perhaps if it is endorsed by a nationally adequate numbers of patients using consistent methods of credible consensus guideline. In such circumstances, outcome measures may be most appropriate. case definition and ascertainment and including sufficient
